gadolinium has been researched along with Phobic Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boehm, I; Heverhagen, JT; Morelli, J; Nairz, K; Silva Hasembank Keller, P | 1 |
| Goischke, HK | 1 |
| Frezza, F; Longo, R; Magnaldi, S; Pozzi-Mucelli, RS; Razavi, IS; Ukmar, M | 1 |
1 review(s) available for gadolinium and Phobic Disorders
| Article | Year |
|---|---|
General anaesthesia for patients with a history of a contrast medium-induced anaphylaxis: a useful prophylaxis?
Topics: Anaphylaxis; Anesthesia, General; Anxiety; Contrast Media; Gadolinium; Humans; Iodine Radioisotopes; Phobic Disorders; Premedication; Secondary Prevention | 2017 |
2 other study(ies) available for gadolinium and Phobic Disorders
| Article | Year |
|---|---|
"Gadolinium-Phobia:" Not a Helpful "Criterion" for Indication for Gadolinium-based Contrast Agent Administration in Multiple Sclerosis.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Phobic Disorders | 2016 |
Assessment of pituitary microadenomas: comparison between 2D and 3D MR sequences.
Topics: Adult; Aged; Artifacts; Contrast Media; Evaluation Studies as Topic; Female; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Humans; Hyperprolactinemia; Image Enhancement; Injections, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Pentetic Acid; Phobic Disorders; Pituitary Neoplasms; Prolactinoma; Prospective Studies; Time Factors | 1997 |